Obesity is the leading cause of diverse metabolic diseases such as diabetes, hypertension, cardiovascular diseases, as well as steatotic liver diseases. Recently, WHO (World Health Organization) officially announced and defined obesity as the 21st century’s pandemic, urging countries and societies to unite and seek for break-through.
Implementing scientific expertise on incretin biology and exceptional R&D capabilities with accumulated know-how, Hanmi is commencing H.O.P. (Hanmi Obesity Pipeline) project to provide proper solution for obesity management by expanding portfolio of not only peptide/protein-based drug design and formulation technology, but also digital therapy.
Hanmi envisions that future medicines derived from H.O.P. project will fully cover the areas of regulating obesity in terms of 1) efficient weight loss, 2) prevention of obesity, and 3) quality of weight loss management.

Cancer is the chief cause of death worldwide, causing many patients to suffer from severe pain. We strive to overcome resistance against existing cancer therapeutics and achieve the ultimate goal of 'Cancer Moonshot.' Extending attempts are being made to enhance the anti-tumor efficacy and expand indications for therapeutics in various cancer therapies including targeted therapy, immunotherapy, antibody therapy, and combination therapy. In addition, we are making efforts to build a pipeline through open innovation utilizing artificial intelligence in the face of the accelerating digital transformation.

Hanmi Pharmaceutical's management philosophy of 'Respect for Humanity' and 'Value Creation' stands out in various fields of new drug development, especially in the 'Rare Diseases.' This is also why Hanmi Pharmaceutical exists, "for a better life for humankind." We are doing our best to develop innovative new drugs that can provide hope to patients worldwide suffering from rare diseases, according to the management philosophy of the founder and former Chairman Sung-ki Lim, who said, "New drug development itself is a social contribution."